Viewing data from:

PERINDOPRIL ERBUMINE

ANDA

PERINDOPRIL ERBUMINE | A079070 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.5629

per ea

Lowest NADAC/Unit

$0.4188

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
65862028801PERINDOPRIL ERBUMINE 8 MG TAB	$0.5629	EA	Generic	—	2026-06-17
65862028701PERINDOPRIL ERBUMINE 4 MG TAB	$0.5147	EA	Generic	—	2026-06-17
65862028601PERINDOPRIL ERBUMINE 2 MG TAB	$0.4188	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs3 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

ALIVUS LIFE SCIENCES LTDPERINDOPRIL ERBUMINE

DMF 177132004

PIRAMAL PHARMA LTDPERINDOPRIL ERBUMINE

DMF 281442014

MSN PHARMACHEM PRIVATE LTDPERINDOPRIL ERBUMINE USP

DMF 414972025

NORAMCO DELAWARE INCInactivePERINDOPRIL ERBUMINE

DMF 91651991

ORIL INDUSTRIEInactivePERINDOPRIL ERBUMINE

DMF 91711991

CIPLA LTDInactivePERINDOPRIL ERBUMINE MONOHYDRATE

DMF 201652007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Nov 13, 2009	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 2MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 10, 2009

No patent or exclusivity listings for this strength.

#002 — 4MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 10, 2009

#003 — 8MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 10, 2009